Can prophylactic breast irradiation contribute to cardiac toxicity in patients with prostate cancer receiving androgen suppressing drugs?

about

Tamoxifen for the management of breast events induced by non-steroidal antiandrogens in patients with prostate cancer: a systematic review Optimal prophylactic and definitive therapy for bicalutamide-induced gynecomastia: results of a meta-analysis

P2860

Q34296202-0A6E1652-95CA-4D9A-BFDD-BE18BF4BE4CE Q34372251-6E60AF93-C551-4188-8F9C-A66E470245F8

P2860

Can prophylactic breast irradiation contribute to cardiac toxicity in patients with prostate cancer receiving androgen suppressing drugs?

Item

http://www.wikidata.org/entity/Q36473630

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Can prophylactic breast irradi ...... ng androgen suppressing drugs?

@ast

Can prophylactic breast irradi ...... ng androgen suppressing drugs?

@en

type

Item

label

Can prophylactic breast irradi ...... ng androgen suppressing drugs?

@ast

Can prophylactic breast irradi ...... ng androgen suppressing drugs?

@en

prefLabel

Can prophylactic breast irradi ...... ng androgen suppressing drugs?

@ast

Can prophylactic breast irradi ...... ng androgen suppressing drugs?

@en

P1476

Can prophylactic breast irradi ...... ng androgen suppressing drugs?

@en

P2093

Adam Pawinski

http://www.w3.org/2001/XMLSchema#string

Carsten Nieder

http://www.w3.org/2001/XMLSchema#string

Michael Molls

http://www.w3.org/2001/XMLSchema#string

Nicolaus H Andratschke

http://www.w3.org/2001/XMLSchema#string

P2860

Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer

Radiation-induced cardiovascular diseases: is the epidemiologic evidence compatible with the radiobiologic data?

Maximal androgen blockade: final analysis of EORTC phase III trial 30853. EORTC Genito-Urinary Tract Cancer Cooperative Group and the EORTC Data Center.

Side effects of androgen deprivation therapy: monitoring and minimizing toxicity.

Determinants of androgen deprivation therapy use for prostate cancer: role of the urologist.

Influence of different treatment techniques on radiation dose to the LAD coronary artery

Long term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis.

Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02.

Prophylactic breast irradiation with a single dose of electron beam radiotherapy (10 Gy) significantly reduces the incidence of bicalutamide-induced gynecomastia.

Efficacy and tolerability of radiotherapy as treatment for bicalutamide-induced gynaecomastia and breast pain in prostate cancer.

P2888

1748-717x-3-2

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1748-717X-3-2

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1048720386

http://www.w3.org/2001/XMLSchema#string

P698

18186924

http://www.w3.org/2001/XMLSchema#string

P932

2249590

http://www.w3.org/2001/XMLSchema#string

Can prophylactic breast irradiation contribute to cardiac toxicity in patients with prostate cancer receiving androgen suppressing drugs?

about

P2860

P2860

Can prophylactic breast irradiation contribute to cardiac toxicity in patients with prostate cancer receiving androgen suppressing drugs?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P6179

P698

P932